- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
XORTX Therapeutics Inc (XRTX)
XORTX Therapeutics Inc stock price live, this page displays NASDAQ XRTX stock exchange data. View the XRTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the XORTX Therapeutics Inc real time stock price chart below.
What Is the XORTX Therapeutics Inc Stock Price Today?
The XORTX Therapeutics Inc stock price today is 2.0850.
What Is the Stock Symbol for XORTX Therapeutics Inc?
The stock symbol for XORTX Therapeutics Inc is "XRTX."
What Stock Exchange Does XORTX Therapeutics Inc Trade On?
XORTX Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is XORTX Therapeutics Inc a Good Stock to Buy?
Determining whether XORTX Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XRTX quote. (ISIN: CA98420Q4051)
What Is the XORTX Therapeutics Inc Stock Price Today?
The XORTX Therapeutics Inc stock price today is 2.0850.
What Is the Stock Symbol for XORTX Therapeutics Inc?
The stock symbol for XORTX Therapeutics Inc is "XRTX."
What Stock Exchange Does XORTX Therapeutics Inc Trade On?
XORTX Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is XORTX Therapeutics Inc a Good Stock to Buy?
Determining whether XORTX Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XRTX quote. (ISIN: CA98420Q4051)
2.0850
-0.0750(-3.47%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.0400
2.1100
52 wk Range
1.7250
7.0500
XRTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.04002.1100
52 wk Range
1.72507.0500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
XRTX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
- Form 6K XORTX Therapeutics Inc For: 15 June
- Investing.com
- Form 6K XORTX Therapeutics Inc For: 12 June
- Investing.com
- Form 6K XORTX Therapeutics Inc For: 15 June
- Investing.com
- Form 6K XORTX Therapeutics Inc For: 12 June
- Investing.com
- Form 6K XORTX Therapeutics Inc For: 19 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
May 16, 2026
EPS / Forecast
-0.58 / --
Revenue / Forecast
-- / --
Compare XRTX to Peers and Sector
Metrics to compare | XRTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipXRTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −2.8x | −0.4x | |
PEG Ratio | 0.02 | 0.00 | 0.00 | |
Price/Book | 2.8x | 1.4x | 2.6x | |
Price / LTM Sales | - | 1.7x | 3.1x | |
Upside (Analyst Target) | - | 230.7% | 48.3% | |
Fair Value Upside | Unlock | 3.7% | 6.1% | Unlock |
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the treatment of autosomal dominant polycystic kidney disease; XRx-101, which is in Phase II for the treatment of acute kidney injury associated with respiratory virus infection, including sepsis and coronavirus; and XRX-225, which is in preclinical stage for the treatment of type 2 diabetic nephropathy, as well as VB4-P5, a program for the treatment and prevention of fibrosis in the kidney. The company is based in Calgary, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the XORTX Therapeutics (XRTX) Stock Price Today?
The XORTX Therapeutics stock price today is 2.0850 USD.
What Stock Exchange Does XORTX Therapeutics Trade On?
XORTX Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for XORTX Therapeutics?
The stock symbol for XORTX Therapeutics is "XRTX."
What Is the XORTX Therapeutics Market Cap?
As of today, XORTX Therapeutics market cap is 3.5600M USD.
What Is XORTX Therapeutics's Earnings Per Share (TTM)?
The XORTX Therapeutics EPS (TTM) is -2.4961.
From a Technical Analysis Perspective, Is XRTX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has XORTX Therapeutics Stock Split?
XORTX Therapeutics has split 3 times.
What is the current trading status of XORTX Therapeutics (XRTX)?
As of Jul 07, 2026, XORTX Therapeutics (XRTX) is trading at a price of 2.0850 USD, with a previous close of 2.0700 USD. The stock has fluctuated within a day range of 2.0400 USD to 2.1100 USD, while its 52-week range spans from 1.7250 USD to 7.0500 USD.
What Is the XRTX Premarket Price?
XRTX's last pre-market stock price is 2.0800 USD. The pre-market share volume is 962.0000, and the stock has decreased by -0.0800, or -3.7000%.
What Is the XRTX After Hours Price?
XRTX's last after hours stock price is 2.1799 USD, the stock has decreased by 0.1099, or 5.3100%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.